219 related articles for article (PubMed ID: 22706350)
1. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
[TBL] [Abstract][Full Text] [Related]
2. A natural products approach to drug discovery: probing modes of action of antitumor agents by genome-scale cDNA library screening.
Luesch H; Abreu P
Methods Mol Biol; 2009; 572():261-77. PubMed ID: 20694698
[TBL] [Abstract][Full Text] [Related]
3. A novel cromakalim analogue induces cell cycle arrest and apoptosis in human cervical carcinoma HeLa cells through the caspase- and mitochondria-dependent pathway.
Zhang X; Zhao J; Kang S; Yi M; You S; Shin DS; Kim DK
Int J Oncol; 2011 Dec; 39(6):1609-17. PubMed ID: 21833470
[TBL] [Abstract][Full Text] [Related]
4. Cell-cycle inhibitor profiling by high-content analysis.
Gasparri F; Ciavolella A; Galvani A
Adv Exp Med Biol; 2007; 604():137-48. PubMed ID: 17695726
[TBL] [Abstract][Full Text] [Related]
5. Establishing a high-throughput and automated cancer cell proliferation panel for oncology lead optimization.
Lei M; Ribeiro H; Kolodin G; Gill J; Wang YS; Maloney D; Fan Y; Li S; Myer L; Beluch M; Zhang L; Schweizer L
J Biomol Screen; 2013 Oct; 18(9):1043-53. PubMed ID: 23733846
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and visualization of diverse cellular phenotypic responses in primary high-content screening.
Kümmel A; Selzer P; Siebert D; Schmidt I; Reinhardt J; Götte M; Ibig-Rehm Y; Parker CN; Gabriel D
J Biomol Screen; 2012 Jul; 17(6):843-9. PubMed ID: 22396475
[TBL] [Abstract][Full Text] [Related]
7. Development of fluorescence imaging-based assay for screening cardioprotective compounds from medicinal plants.
Wang Y; Zhao X; Gao X; Nie X; Yang Y; Fan X
Anal Chim Acta; 2011 Sep; 702(1):87-94. PubMed ID: 21819864
[TBL] [Abstract][Full Text] [Related]
8. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric cell-based assay for the evaluation of transcription inhibition by high-content imaging.
Torres-Guzmán R; Chu S; Velasco JA; Lallena MJ
J Biomol Screen; 2013 Jun; 18(5):556-66. PubMed ID: 23307837
[TBL] [Abstract][Full Text] [Related]
10. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
11. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
Griffiths M; Sundaram H
Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
[TBL] [Abstract][Full Text] [Related]
12. Reducing the multidimensionality of high-content screening into versatile powerful descriptors.
Gorenstein J; Zack B; Marszalek JR; Bagchi A; Subramaniam S; Carroll P; Elbi C
Biotechniques; 2010 Sep; 49(3):663-5. PubMed ID: 20854269
[TBL] [Abstract][Full Text] [Related]
13. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
Evensen L; Micklem DR; Link W; Lorens JB
Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
[TBL] [Abstract][Full Text] [Related]
14. Visualization and interpretation of high content screening data.
Smellie A; Wilson CJ; Ng SC
J Chem Inf Model; 2006; 46(1):201-7. PubMed ID: 16426056
[TBL] [Abstract][Full Text] [Related]
15. A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays.
Chan GK; Kleinheinz TL; Peterson D; Moffat JG
PLoS One; 2013; 8(5):e63583. PubMed ID: 23691072
[TBL] [Abstract][Full Text] [Related]
16. Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening.
Cappella P; Giorgini ML; Ernestina Re C; Ubezio P; Ciomei M; Moll J
Cytometry A; 2010 Oct; 77(10):953-61. PubMed ID: 21290469
[TBL] [Abstract][Full Text] [Related]
17. An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells.
Kumar A; Malik F; Bhushan S; Sethi VK; Shahi AK; Kaur J; Taneja SC; Qazi GN; Singh J
Chem Biol Interact; 2008 Feb; 171(3):332-47. PubMed ID: 18070620
[TBL] [Abstract][Full Text] [Related]
18. Development and implementation of multiplexed cell-based imaging assays.
Howell BJ; Lee S; Sepp-Lorenzino L
Methods Enzymol; 2006; 414():284-300. PubMed ID: 17110198
[TBL] [Abstract][Full Text] [Related]
19. [High content screening in chemical biology: overview and main challenges].
Brodin P; DelNery E; Soleilhac E
Med Sci (Paris); 2015 Feb; 31(2):187-96. PubMed ID: 25744266
[TBL] [Abstract][Full Text] [Related]
20. Precision multidimensional assay for high-throughput microRNA drug discovery.
Haefliger B; Prochazka L; Angelici B; Benenson Y
Nat Commun; 2016 Feb; 7():10709. PubMed ID: 26880188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
